Authors:
Verhoeven, AC
Boers, M
Koppele, JMT
van der Laan, WH
Markusse, HM
Geusens, P
van der Linden, S
Citation: Ac. Verhoeven et al., Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone, RHEUMATOLOG, 40(11), 2001, pp. 1231-1237
Authors:
Watts, NB
Jenkins, DK
Visor, JM
Casal, DC
Geusens, P
Citation: Nb. Watts et al., Comparison of bone and total alkaline phosphatase and bone mineral densityin postmenopausal osteoporotic women treated with alendronate, OSTEOPOR IN, 12(4), 2001, pp. 279-288
Authors:
Geusens, P
Vosse, D
van der Heijde, D
Vanhoof, J
van Tubergen, A
Raus, J
van der Linden, S
Citation: P. Geusens et al., High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis, J RHEUMATOL, 28(8), 2001, pp. 1856-1861
Authors:
McClung, MR
Geusens, P
Miller, PD
Zippel, H
Bensen, WG
Roux, C
Adami, S
Fogelman, I
Diamond, T
Eastell, R
Meunier, PJ
Reginster, JY
Wasnich, RD
Greenwald, M
Kaufman, J
Chestnut, CH
Citation: Mr. Mcclung et al., Effect of risedronate on the risk of hip fracture in elderly women, N ENG J MED, 344(5), 2001, pp. 333-340
Authors:
VanderBorght, A
Geusens, P
Vandevyver, C
Raus, J
Stinissen, P
Citation: A. Vanderborght et al., Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient, RHEUMATOLOG, 39(11), 2000, pp. 1189-1201
Authors:
Theiler, R
Stahelin, HB
Kranzlin, M
Somorjai, G
Singer-Lindpaintner, L
Conzelmann, M
Geusens, P
Bischoff, HA
Citation: R. Theiler et al., Influence of physical mobility and season on 25-hydroxyvitamin D-parathyroid hormone interaction and bone remodelling in the elderly, EUR J ENDOC, 143(5), 2000, pp. 673-679
Citation: P. Geusens, Hormonal replacement therapy in the prevention and treatment of glucocorticoid-induced osteoporosis, CLIN EXP RH, 18(5), 2000, pp. S57-S59
Authors:
Adachi, JD
Roux, C
Pitt, PI
Cooper, C
Moniz, C
Dequeker, J
Ioannidis, G
Cawley, MID
Jenkins, EA
Walker-Bone, KE
Pack, S
Stephenson, GF
Laan, RF
Brown, J
Geusens, P
Citation: Jd. Adachi et al., A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss, J RHEUMATOL, 27(10), 2000, pp. 2424-2431
Authors:
Jiang, YB
Zhao, J
Rosen, C
Geusens, P
Genant, HK
Citation: Yb. Jiang et al., Perspectives on bone mechanical properties and adaptive response to mechanical challenge, J CLIN DENS, 2(4), 1999, pp. 423-433
Authors:
Vandevyver, C
Vanhoof, J
Declerck, K
Stinissen, P
Vandervorst, C
Michiels, L
Cassiman, JJ
Boonen, S
Raus, J
Geusens, P
Citation: C. Vandevyver et al., Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women, J BONE MIN, 14(9), 1999, pp. 1576-1582
Authors:
VanderBorght, A
Van der Aa, A
Geusens, P
Vandevyver, C
Raus, J
Stinissen, P
Citation: A. Vanderborght et al., Identification of overrepresented T cell receptor genes in blood and tissue biopsies by PCR-ELISA, J IMMUNOL M, 223(1), 1999, pp. 47-61
Citation: P. Geusens et S. Boonen, Risk assessment for osteoporosis using bone mineral density determination - A Belgian perspective, J CLIN DENS, 1(4), 1998, pp. 355-358
Authors:
Geusens, P
Dequeker, J
Vanhoof, J
Stalmans, R
Boonen, S
Joly, J
Nijs, J
Raus, J
Citation: P. Geusens et al., Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind,randomised placebo controlled study, ANN RHEUM D, 57(12), 1998, pp. 724-727